Rakuten Medical Announces New Name “Alluminox™” for its Proprietary Technology Platform


Rakuten Medical, Inc. (Rakuten Medical) has elected to discontinue use of  the name “Illuminox,” and to start using a new, evolved name “Alluminox™” for our proprietary, anti-cancer, photoimmunotherapy technology platform, which is comprised of drug, medical device, and other related technologies. This name change will take effect globally from April 1, 2022.

Read More

Next Post

The Pandemic Can Pave the Way to Better Mental Health Care

The COVID-19 pandemic has strained our social fabric in so many ways. Above all, there is the loss of life, which has occurred at an unfathomable scale and is still ongoing. But in addition, with the necessary disruptions in our educational system, we’ve seen the struggles of families trying to […]